Deals
Instead of looking at the year past, OIS Weekly is wrapping up 2017 by looking at the year ahead. Here’s a rundown of significant regulatory…
Read More
Can Conference Save Orphan Drug Tax Credit? Orphan drug developers will be watching closely in the next few days as the GOP’s tax reform package…
Read More
For the third straight month, the OIS Index outperformed the NASDAQ Biotechnology Index. The OIS Index gained 2.6% in November, nearly matching the performance of…
Read More
Here’s a review of clinical trial results and new technology rolled out at the latest gathering of the American Academy of Ophthalmology in New Orleans.…
Read More
The OIS Index is a composite of ophthalmic growth stocks that tracks the investment performance of our sector. Our goal is to highlight ophthalmology investment…
Read MoreLet’s just say there’s too much happening at OIS@AAO 2017 next week to capsulize it all in a tidy preview, but with the ninth iteration…
Read More
With the unanimous endorsement from a Food and Drug Administration advisory committee that Spark Therapeutics’ Luxturna gene therapy for biallelic RPE65 mutation-associated retinal dystrophy should…
Read More
What’s Happening in the Month Ahead: October 2017 The Food and Drug Administration along with a host of professional societies, including the American Academy of…
Read More
One year ago, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is…
Read More
When Veracity Innovations LLC launched its new product at the 2017 American Society of Cataract and Refractive Surgery meeting in Los Angeles, the company was…
Read More
Last October, we launched the OIS Index, a composite of ophthalmic growth stocks, to track the investment performance of our sector. Our goal is to…
Read More
The annual meeting of the American Society of Retina Specialists featured four days of scientific sessions. Among the notable updates on key clinical trials from…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")